Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein (Q38474705)
Jump to navigation
Jump to search
scientific article published on May 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein |
scientific article published on May 1997 |
Statements
1 reference
Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein (English)
1 reference
Han S
1 reference
Yun IJ
1 reference
Noh DY
1 reference
Choe KJ
1 reference
Song SY
1 reference
Chi JG
1 reference
1 reference
Identifiers
1 reference